| Abstrakt: |
L-Nutra Inc., a nutri-technology company focused on longevity science nutrition programs, has closed a $47 million investment in its Series D fund raising. The investment round was led by Mr. Stephane Bancel, CEO of Moderna Inc., and Brentwood Associates. L-Nutra was founded in 2009 by the University of Southern California (USC) and Dr. Valter Longo, Director of the Longevity Institute at USC. The company has developed the ProLon(R) Nutrition for Longevity pipeline and the L-Nutra Health Nutrition as Medicine pipeline, aimed at improving metabolic health and enhancing patients' chances of remission from various diseases. The investment will support the expansion of ProLon(R) and increase access to the diabetes remission program. [Extracted from the article] |
